...
首页> 外文期刊>Strahlentherapie und Onkologie >Dosimetric integration of daily mega-voltage cone-beam CT for image-guided intensity-modulated radiotherapy.
【24h】

Dosimetric integration of daily mega-voltage cone-beam CT for image-guided intensity-modulated radiotherapy.

机译:每日巨型电压锥束CT的剂量学集成,用于图像引导的强度调制放射治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The goal of this work was to compare different methods of incorporating the additional dose of mega-voltage cone-beam CT (MV-CBCT) for image-guided intensity modulated radiotherapy (IMRT) of different tumor entities.The absolute dose delivered by the MV-CBCT was calculated and considered by creating a scaled IMRT plan (scIMRT) by renormalizing the clinically approved plan (orgIMRT) so that the sum with the MV-CBCT dose yields the same prescribed dose. In the other case, a newly optimized plan (optIMRT) was generated by including the dose distribution of the MV-CBCT as pre-irradiation. Both plans were compared with the orgIMRT plan and a plan where the last fraction was skipped.No significant changes were observed regarding the 95% conformity index of the target volume. The mean dose of the organs at risk (OAR) increased by approx. 7% for the scIMRT plan and 5% for the optIMRT plan. A significant increase of the mean dose to the outline contour was observed, ranging from 3.1?±?1.3% (optIMRT) to 13.0?±?6.1% (scIMRT) for both methods over all entities. If the dose of daily MV-CBCT would have been ignored, the additional dose accumulated to nearly a whole treatment fraction with a general increase of approx. 10% to the OARs and approx. 4% to the target volume.Both methods of incorporating the additional MV-CBCT dose into the treatment plan are suitable for clinical practice. The dose distribution of the target volume could be achieved as conformal as with the orgIMRT plan, while only a moderate increase of mean dose to OAR was observed.
机译:这项工作的目的是比较不同剂量的大剂量锥束CT(MV-CBCT)合并剂量用于不同肿瘤实体的图像引导强度调制放射治疗(IMRT)的方法。通过重新标准化临床批准的计划(orgIMRT)来创建缩放的IMRT计划(scIMRT),从而计算和考虑-CBCT,以使MV-CBCT剂量的总和产生相同的处方剂量。在另一种情况下,通过将MV-CBCT的剂量分布作为预辐照来生成新优化的计划(optIMRT)。将这两个计划与orgIMRT计划以及跳过最后一个分数的计划进行了比较。对于目标量的95%合格指数,未观察到重大变化。处于危险状态的器官(OAR)的平均剂量增加了约。 scIMRT计划为7%,optIMRT计划为5%。在所有实体上,两种方法的轮廓轮廓平均剂量均显着增加,范围从3.1±±1.3%(optIMRT)到13.0±±6.1%(scIMRT)。如果将忽略每日MV-CBCT的剂量,则额外的剂量将累积到几乎整个治疗阶段,并且一般会增加约5%。 OAR的10%左右目标体积的4%。两种将额外MV-CBCT剂量合并到治疗计划中的方法均适合临床实践。与orgIMRT计划一样,可以实现目标体积的剂量分布,但仅观察到OAR的平均剂量适度增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号